| dbo:abstract
|
- 1,3-Dimethylbutylamin (auch: DMBA) ist eine organische Verbindung aus der Gruppe der aliphatischen Amine. Die Verbindung ist mit Methylhexanamin (DMAA) verwandt. (de)
- 1,3-Dimethylbutylamine (1,3-DMBA, dimethylbutylamine, DMBA, 4-amino-2-methylpentane, or AMP), is a stimulant drug structurally related to methylhexanamine where a butyl group replaces the pentyl group. The compound is an aliphatic amine. The hydrochloride and citrate salts of DMBA has been identified as unapproved ingredients in some over-the-counter dietary supplements, in which it is used in an apparent attempt to circumvent bans on methylhexanamine. The U.S. Food and Drug Administration (FDA) considers any dietary supplement containing DMBA to be "adulterated". Despite the FDA's opposition, DMBA continues to be sold in the US. There are no known human safety studies on DMBA and its health effects are entirely unknown. (en)
- 1,3-二甲基丁胺（1,3-DMBA、二甲基丁胺、DMBA、4-氨基-2-甲基戊烷或AMP）是一种兴奋剂，其结构与甲基己胺的差别在于丁基取代了戊基。该化合物是一种脂肪胺。 DMBA的盐酸盐和柠檬酸盐被确定为非处方膳食补充剂中的未经批准的成分，使用它们显然是为了规避对甲基己胺的禁令。美国食品药品监督管理局（FDA）认为任何含有DMBA的膳食补充剂都是“掺假的”。尽管DMBA受到FDA的反对，它仍继续在美国销售。 目前没有关于DMBA的人体安全研究，其健康影响完全未知。 (zh)
|
| dbo:alternativeName
|
- (4-Methylpentan-2-yl)amine (en)
|
| dbo:iupacName
|
- 4-Methylpentan-2-amine (en)
|
| dbo:thumbnail
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 4646 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:imagecaptionl
| |
| dbp:imagecaptionr
| |
| dbp:imagefile
|
- Dimethylbutylamine.svg (en)
|
| dbp:imagefilel
| |
| dbp:imagefiler
| |
| dbp:imagesizel
| |
| dbp:imagesizer
| |
| dbp:othernames
| |
| dbp:pin
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| gold:hypernym
| |
| rdf:type
| |
| rdfs:comment
|
- 1,3-Dimethylbutylamin (auch: DMBA) ist eine organische Verbindung aus der Gruppe der aliphatischen Amine. Die Verbindung ist mit Methylhexanamin (DMAA) verwandt. (de)
- 1,3-二甲基丁胺（1,3-DMBA、二甲基丁胺、DMBA、4-氨基-2-甲基戊烷或AMP）是一种兴奋剂，其结构与甲基己胺的差别在于丁基取代了戊基。该化合物是一种脂肪胺。 DMBA的盐酸盐和柠檬酸盐被确定为非处方膳食补充剂中的未经批准的成分，使用它们显然是为了规避对甲基己胺的禁令。美国食品药品监督管理局（FDA）认为任何含有DMBA的膳食补充剂都是“掺假的”。尽管DMBA受到FDA的反对，它仍继续在美国销售。 目前没有关于DMBA的人体安全研究，其健康影响完全未知。 (zh)
- 1,3-Dimethylbutylamine (1,3-DMBA, dimethylbutylamine, DMBA, 4-amino-2-methylpentane, or AMP), is a stimulant drug structurally related to methylhexanamine where a butyl group replaces the pentyl group. The compound is an aliphatic amine. There are no known human safety studies on DMBA and its health effects are entirely unknown. (en)
|
| rdfs:label
|
- 1,3-Dimethylbutylamin (de)
- 1,3-Dimethylbutylamine (en)
- 1,3-二甲基丁胺 (zh)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
-4-Methyl-2-aminopentan.svg){kind=link}
-4-Methyl-2-aminopentan.svg){kind=link}
